Theravance Biopharma Inc (TBPH) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 941.43M |
| Enterprise Value | 849.12M |
| P/E Ratio | 15.99 |
| PEG Ratio | 0.05 |
| Price/Sales Ratio | 8.45 |
| Price/Book Ratio | 3.03 |
| Enterprise/Revenue | 6.71 |
| Enterprise/EBITDA | 10.23 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.52 |
| Operating Margin | 0.04 |
| Return On Assets | 0.11 |
| Return On Equity | 0.19 |
| Revenue | 107.46M |
| Revenue/Share | 2.02 |
| Gross Profit | 101.95M |
| EBITDA | 137.22M |
| Net Income | 105.9M |
| Diluted EPS | 2.06 |
| Total Cash | 387.66M |
| Total Cash/Share | 7.5 |
| Total Debt | 38.57M |
| Total Debt/Equity | 0.13 |
| Current Ratio | 13.54 |
| Book Value Per Share | 5.61 |
| 52-Week Change | 23.26 |
| 52-Week High | 21.03 |
| 52-Week Low | 13.08 |
| Moving Average 50 Days | 16.9 |
| Moving Average 200 Days | 17.25 |
| Average Volume | 648,554 |
| Shares Outstanding | 51.83M |
| % Held by Institutions | 94.16 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |